id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-254452-gqqdx2r5	Singh, Awadhesh Kumar	Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies	2020-05-12		.txt	text/plain	3162	163	47	METHODS: We systematically searched the PubMed, ClinicalTrial.Org and MedRxiv database up till May 5, 2020 using specific key words such as "Remdesivir" or 'GS-5734″ AND "COVID-19" or "SARS-CoV-2" and retrieved all the article published in English language, that have reported the pharmacology and the clinical outcomes of remdesivir in patients with COVID-19. A preliminary report (April 29, 2020) from an interim analysis of an ongoing double-blind randomized controlled trial (RCT) recently suggested that remdesivir had a 31% faster time to recovery, compared to the placebo (p<0.001), in patients with COVID-19 [15] . In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial	./cache/cord-254452-gqqdx2r5.txt	./txt/cord-254452-gqqdx2r5.txt